Biogénesis Bagó MENA

Biogénesis Bagó MENA Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Biogénesis Bagó MENA, Biotechnology company, Doha.

We are the Middle East and North African subsidiary of Biogénesis Bagó, a biotechnology company specialized in the development, manufacturing and commercialization of solutions for animal and environmental health.

27/07/2026

Brazil’s livestock sector is far more than an industry, it is a national treasure that powers millions of livelihoods, sustains entire communities, and feeds millions across the globe. Decades of hard work built this legacy, but preserving it requires cutting-edge science, continuous technology, and unwavering preparedness.

In an animal health emergency, every second counts. That is why Biogénesis Bagó is honored to join forces with Tecpar and the Ministry of Agriculture of Brazil in establishing the National Antigen Bank for the Emergency Response to FMD.

By uniting decades of global biotechnology experience with public-sector strategy, we are constructing a rapid, secure, and coordinated line of defense for the national herd. Because protecting animal health goes far beyond the farm, it safeguards jobs, protects food security, and secures the future.

Some investments aren't just for today, they are built to protect tomorrow.

The best way to respond to an animal health emergency is to be prepared before it happens.We welcomed Brazil’s Minister ...
21/07/2026

The best way to respond to an animal health emergency is to be prepared before it happens.

We welcomed Brazil’s Minister of AgriBiogenesisBagovestock (MAPA), André de Paula, and representatives from the Paraná Institute of Technology (TECPAR) at our Garín facility (Argentina) for the official handover ceremony of Brazil’s National Antigen Bank for Emergency Response to Foot-and-Mouth Disease.

An antigen bank is a strategic reserve that enables the rapid formulation of vaccines in the event of an outbreak, ensuring timely access to critical animal health response tools.

This resource was established to strengthen Brazil’s preparedness and rapid response capacity for potential foot-and-mouth disease emergencies and is part of the long-term agreement between Biogénesis Bagó, MAPA, and TECPAR.

The initiative brings together planning, technological innovation, and public-private collaboration to further strengthen animal health protection and the resilience of Brazil’s livestock production.

Staying ahead of Foot-and-Mouth Disease (FMD) means staying ahead of the virus itself. We are proud to share that a rece...
15/07/2026

Staying ahead of Foot-and-Mouth Disease (FMD) means staying ahead of the virus itself. We are proud to share that a recent independent heterologous challenge trial conducted by the prestigious Wageningen Bioveterinary Research (FAO reference center) has demonstrated that BIOAFTOGEN® SAT1 provides robust protection against the pandemic SAT1 topotype III FMD virus.

This study represents the first global challenge-study evidence of cross-protection against this emerging strain, showcasing 86% protection after just a single dose, and reaching 100% protection following a two-dose schedule.

Circulating field strains frequently mutate and differ antigenically from the strains included in standard vaccines. Demonstrating high-level protection against a heterologous (different) strain provides critical, real-world proof of cross-protection. These results reinforce the vital role that high-potency, rigorously tested vaccines play in global FMD preparedness and disease-control strategies.

For Biogénesis Bagó, these landmark results reflect decades of unwavering investment in world-class science and innovation. Because when global animal health is on the line, you need solutions that are tested, validated, and ready for real-world challenges.

Read more about how we are securing the livestock sector against emerging global threats.

Link in Bio!

SAT1 is expanding beyond its traditional boundaries, making timely information more important than ever. 🌍The latest edi...
08/07/2026

SAT1 is expanding beyond its traditional boundaries, making timely information more important than ever. 🌍

The latest edition of the Biogénesis Bagó MENA Quarterly Newsletter is now available, bringing together the latest developments shaping the global Foot-and-Mouth Disease landscape.

Inside this issue:

🔹 SAT1 expansion across Europe, Asia, and MENA🔹 Regional epidemiological updates and risk assessment
🔹 Technical guidance on selecting an effective FMD vaccine
🔹 Biogénesis Bagó’s latest field activities and partnerships

Preparedness begins with informed decisions. Stay up to date with the latest scientific insights and regional developments to help strengthen your FMD prevention strategy.

🔗 Download the latest issue from our bio.

06/07/2026

⚠️ Warning signs to watch for

A BIOAFTOGEN®️ product may be unverified:
1.⁠If ⁠it is sold outside authorized distributors
2.⁠ ⁠If the packaging lacks clear information
3.⁠ ⁠If the label looks inconsistent
4.⁠ If ⁠the origin cannot be identified
5.⁠ If ⁠it is offered through informal channels

If you have any questions, please contact us at [email protected]
More information: Website in our Bio

01/07/2026

⚠️ Important notice

We have identified social media posts offering products labeled as BIOAFTOGEN®️ outside official channels.

Before using any veterinary product, always verify that the packaging and label match the officially approved version in your country and that the product has been obtained through authorized channels.

Using unverified products may put animal health at risk and affect vaccination programs.

If you have any questions, please contact us at [email protected]
More information: Website in our Bio

21/06/2026

⚠️ Important notice

We have identified social media postBioaftogen products labeled as BIOAFTOGEN® outside official channels.

Before using any veterinary product, always check that the packaging and label match the official version used in authorized campaigns, including a valid registration number and batch number.

Using unverified products may put animal health at risk and affect vaccination programs.

If you have any questions, please contact us at [email protected]
More information: Website in our Bio

Le 11 juin 2026, Biogénesis Bagó Mena s'est jointe à la Direction générale des services vétérinaires (DGSV) et aux princ...
16/06/2026

Le 11 juin 2026, Biogénesis Bagó Mena s'est jointe à la Direction générale des services vétérinaires (DGSV) et aux principaux acteurs du secteur pour une réunion de travail cruciale en Tunisie. Cette réunion a permis de réaffirmer notre engagement commun à renforcer le dialogue et les partenariats qui protègent l'agriculture de notre région.

En tant que partenaire mondial en biotechnologie, nous avons eu le privilège d'explorer de nouvelles perspectives de développement, des innovations technologiques de pointe et des opportunités essentielles de transfert de technologies, destinées à optimiser les programmes nationaux de prévention et de prophylaxie.

Notre priorité commune est restée claire tout au long de la session :

• Promouvoir l'approche « Une seule santé » : Reconnaître que le bien-être animal est directement lié à la santé humaine et à la stabilité mondiale.

• Garantir l'approvisionnement alimentaire : Déployer une technologie vaccinale de pointe pour soutenir les filières d'élevage locales et préserver l'économie nationale.

• Relever les défis actuels : Favoriser une coordination continue afin de garantir aux agriculteurs tunisiens un accès optimal aux solutions les plus efficaces et scientifiquement validées.

Nous tenons à remercier la DGSV d'avoir organisé cette consultation essentielle. En collaborant étroitement avec les autorités réglementaires, nous veillons à ce que l'évolution de la santé animale continue de garantir la sécurité, la productivité et la résilience sur le terrain.

Découvrez les moments forts de cette réunion marquante ! ➡️

12/06/2026

With animal diseases causing over 20% of global livestock losses, contrasted against a mere 0.6% investment in animal health expenditure, participating in high-level dialogue is no longer optional. It is a global necessity.

At the WOAH General Assembly in Paris, Biogénesis Bagó joined international health authorities to advocate for proactive prevention in light of the increasingly complex global sanitary landscape. We are addressing these challenges head-on by deploying our core strategic assets:

•⁠ ⁠Massive Industrial Scale: Sustaining global vaccination campaigns seamlessly.
•⁠ ⁠Frontline Crisis Know-How: Decades of experience managing complex health emergencies.
•⁠ ⁠The 'One Health' Approach: Active, multidisciplinary collaboration to safeguard food security and economic stability.

Elevating animal health on the global stage is the only way to anticipate future crises and secure the future of livestock production.

Address

Doha

Website

,

Alerts

Be the first to know and let us send you an email when Biogénesis Bagó MENA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category